A sell-the-news reaction to a strong quarter can create the perfect setup for a powerful rebound. Jeremy Mullin explains how to recognize these irrational moves and outlines three steps to trade them for big returns.
Axon Enterprise currently looks noticeably stronger on revenue, demonstrating more sustained high rates of growth compared to Celsius. Over the last eight quarters, Axon Enterprise reported 30%+ growth in every quarter, whereas Celsius has shown a deceleration.
BlackRock Inc. grew its holdings in shares of Axon Enterprise, Inc (NASDAQ: AXON) by 4.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,334,551 shares of the biotechnology company's stock after purchasing an additional 345,365 shares during the period. BlackRock Inc.
ABN Amro Investment Solutions cut its stake in shares of Axon Enterprise, Inc (NASDAQ: AXON) by 25.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,849 shares of the biotechnology company's stock after selling 1,956 shares during the quarter. ABN Amro Investment